Literature DB >> 1432033

The role of radiotherapy in the treatment of subtotally resected benign meningiomas.

R Miralbell1, R M Linggood, S de la Monte, K Convery, J E Munzenrider, R O Mirimanoff.   

Abstract

Thirty-six patients with benign meningioma were treated for primary or recurrent disease by subtotal resection and external beam irradiation from 1968-1986 at Massachusetts General Hospital. Comparison is made with 79 patients treated by subtotal surgery alone from 1962-1980. Progression-free survival for 17 patients irradiated after initial incomplete surgery was 88% at 8 years compared with 48% for similar patients treated by surgery alone (p = 0.057). 16 patients incompletely resected at time of first recurrence were irradiated and 78% were progression-free at 8 years while 11% of a similar group treated by surgery alone were progression free (p = 0.001). Long term overall survival was high and similar in both control and study groups. Two patients were irradiated at second recurrence and 1 patient at third recurrence. Twenty-five patients were treated with photons alone and have a median follow-up of 57 months, 6 patients have recurred at doses 45-60 Gy. Eleven patients were treated with combined 10 MV photons and 160 MV protons utilizing 3-D treatment planning. These patients have been followed for a median of 53 months and none have failed to date. Eight of 11 received 54-60.4 Gy and 3/11 greater than 64.48 Gy. Sex, age, pathology grade and score, surgery and timing of radiation therapy were not associated with significant differences in failure patterns within the irradiated study group (p less than 0.1). Complications have been seen in 6 irradiated patients.

Entities:  

Mesh:

Year:  1992        PMID: 1432033     DOI: 10.1007/bf00172765

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  17 in total

Review 1.  Intracranial tumors: response and resistance to therapeutic endeavors, 1970-1980.

Authors:  H J Bloom
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982-07       Impact factor: 7.038

2.  Irradiation of meningioma: a prototype circumscribed tumor for planning high-dose irradiation of the brain.

Authors:  M Friedman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1977 Sep-Oct       Impact factor: 7.038

3.  Histopathologic features predicting recurrence of meningiomas following subtotal resection.

Authors:  S M de la Monte; J Flickinger; R M Linggood
Journal:  Am J Surg Pathol       Date:  1986-12       Impact factor: 6.394

4.  Role of radiation therapy in the management of meningioma.

Authors:  R J Carella; J Ransohoff; J Newall
Journal:  Neurosurgery       Date:  1982-03       Impact factor: 4.654

5.  The recurrence of intracranial meningiomas after surgical treatment.

Authors:  A B Adegbite; M I Khan; K W Paine; L K Tan
Journal:  J Neurosurg       Date:  1983-01       Impact factor: 5.115

6.  Radiation therapy in the treatment of partially resected meningiomas.

Authors:  N M Barbaro; P H Gutin; C B Wilson; G E Sheline; E B Boldrey; W M Wara
Journal:  Neurosurgery       Date:  1987-04       Impact factor: 4.654

7.  Recurrence of intracranial meningiomas, with special reference to radiotherapy.

Authors:  J Yamashita; H Handa; K Iwaki; M Abe
Journal:  Surg Neurol       Date:  1980-07

8.  Tentorial meningiomas: surgical experience with 61 cases and long-term results.

Authors:  B Guidetti; P Ciappetta; M Domenicucci
Journal:  J Neurosurg       Date:  1988-08       Impact factor: 5.115

9.  Radiation therapy in the treatment of meningioma: the Joint Center for Radiation Therapy experience 1970 to 1982.

Authors:  A R Forbes; I D Goldberg
Journal:  J Clin Oncol       Date:  1984-10       Impact factor: 44.544

10.  Recurrence of meningiomas after operation.

Authors:  S M Marks; H L Whitwell; R H Lye
Journal:  Surg Neurol       Date:  1986-05
View more
  25 in total

1.  Impaired survival and long-term neurological problems in benign meningioma.

Authors:  Hanna van Alkemade; Michelle de Leau; Edith M T Dieleman; Jan W P F Kardaun; Rob van Os; W Peter Vandertop; Wouter R van Furth; Lukas J A Stalpers
Journal:  Neuro Oncol       Date:  2012-03-09       Impact factor: 12.300

Review 2.  Fractionated radiotherapy for intracranial meningiomas.

Authors:  Vinai Gondi; Wolfgang A Tome; Minesh P Mehta
Journal:  J Neurooncol       Date:  2010-09-01       Impact factor: 4.130

Review 3.  New prospects for management and treatment of inoperable and recurrent skull base meningiomas.

Authors:  Mahlon D Johnson; Burak Sade; Michael T Milano; Joung H Lee; Steven A Toms
Journal:  J Neurooncol       Date:  2007-07-12       Impact factor: 4.130

4.  Role of external beam radiotherapy in the treatment of relapsing meningioma.

Authors:  M Buglione; B De Bari; F Trevisan; P Ghirardelli; S Pedretti; L Triggiani; S M Magrini
Journal:  Med Oncol       Date:  2014-02-07       Impact factor: 3.064

5.  Radiosurgery and stereotactic radiotherapy with cyberknife system for meningioma treatment.

Authors:  Rossella Di Franco; Valentina Borzillo; Vincenzo Ravo; Sara Falivene; Francesco Jacopo Romano; Matteo Muto; Fabrizio Cammarota; Giuseppe Totaro; Gianluca Ametrano; Sabrina Rossetti; Carla Cavaliere; Carmine D' Aniello; Gelsomina Iovane; Maria Assunta Porricelli; Massimiliano Berretta; Gerardo Botti; Luigi Starace; Enrico La Salvia; Gaetano Facchini; Paolo Muto
Journal:  Neuroradiol J       Date:  2017-12-05

Review 6.  Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review.

Authors:  Leland Rogers; Igor Barani; Marc Chamberlain; Thomas J Kaley; Michael McDermott; Jeffrey Raizer; David Schiff; Damien C Weber; Patrick Y Wen; Michael A Vogelbaum
Journal:  J Neurosurg       Date:  2015-01       Impact factor: 5.115

7.  Hydroxyurea chemotherapy for unresectable or residual meningioma.

Authors:  H B Newton; M A Slivka; C Stevens
Journal:  J Neurooncol       Date:  2000-09       Impact factor: 4.130

8.  Atypical and anaplastic meningiomas--does the new WHO-classification of brain tumours affect the indication for postoperative irradiation?

Authors:  W Hoffmann; H Mühleisen; C F Hess; R D Kortmann; B Schmidt; E H Grote; M Bamberg
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

9.  Fractionated stereotactic radiotherapy for parasellar meningiomas: a preliminary report of visual outcomes.

Authors:  R S Behbehani; T McElveen; R C Sergott; D W Andrews; P J Savino
Journal:  Br J Ophthalmol       Date:  2005-02       Impact factor: 4.638

10.  Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).

Authors:  Patrick Y Wen; W K Alfred Yung; Kathleen R Lamborn; Andrew D Norden; Timothy F Cloughesy; Lauren E Abrey; Howard A Fine; Susan M Chang; H Ian Robins; Karen Fink; Lisa M Deangelis; Minesh Mehta; Emmanuelle Di Tomaso; Jan Drappatz; Santosh Kesari; Keith L Ligon; Ken Aldape; Rakesh K Jain; Charles D Stiles; Merrill J Egorin; Michael D Prados
Journal:  Neuro Oncol       Date:  2009-12       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.